Neuronetics, Inc.

NASDAQ:STIM

Medical - Diagnostics & Research

Healthcare
$1.24 +0.31%

+$0.00 today

Market cap
$96.38M
Beta
1.04
P/E (TTM)
-2.3
EPS (TTM)
-$0.53
52W Low $0.80High $4.85

Volume 1.66M

Average 2.44M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$20.37M

FY 2025 · Annual

Investing Cash Flow

-$801,000.00

FY 2025 · Annual

Financing Cash Flow

$35.85M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(31.19M)(37.16M)(30.19M)(43.73M)(39.14M)
Depreciation & Amortization1.06M1.65M2.01M2.07M3.47M
Deferred Income Tax00000
Stock-Based Compensation7.87M8.75M7.32M5.6M6.85M
Change in Working Capital(6.64M)(5.12M)(14.1M)(6.81M)6.58M
Accounts Receivables(3.05M)(6.66M)(8.83M)(3.73M)3.54M
Inventory(3.44M)(2.59M)(1.1M)3.15M(395K)
Accounts Payables276K(1.97M)2.03M(1.99M)(1.75M)
Other Working Capital(415K)6.1M(6.2M)(4.25M)5.18M
Other Non-Cash Items918K1.14M2.93M11.86M1.87M
Operating Cash Flow(27.98M)(30.74M)(32.04M)(31M)(20.37M)
Capital Expenditures(2.35M)(3.27M)(2.37M)(1.47M)(801K)
Acquisitions (Net)000(2.55M)0
Purchases of Investments00000
Sales of Investments324K000(31K)
Other Investing Activities(7.81M)10M1.05M1.61M31K
Investing Cash Flow(9.84M)6.73M(1.32M)(2.41M)(801K)
Debt Repayment0023.8M(2.52M)9.62M
Common Stock Issued80.97M00026.82M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities2.03M207K(1.1M)(4.29M)(594K)
Financing Cash Flow83.01M207K22.7M(6.81M)35.85M
Effect of Forex Changes00000
Net Change in Cash45.18M(23.8M)(10.66M)(40.22M)14.68M
Free Cash Flow(30.34M)(34.01M)(34.41M)(32.46M)(21.18M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$39.1M
+ D&A$3.5M
+ Stock-Based Comp$6.8M
+ Deferred Tax$0
+ Working Capital$6.6M
+ Other Non-Cash$1.9M
= Operating Cash Flow-$20.4M
- Capex-$801.0K
= Free Cash Flow-$21.2M

Analysis

FY2025 free cash flow is -$21.2M. FCF conversion is 54.1% of net income. Operating cash flow was -$20.4M, with capex of -$801.0K. The largest bridge item is Stock-Based Comp at $6.8M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
8-KCurrent reportNov 12, 2026
424B5424B5 filingNov 12, 2026
8-K/A8-K/A filingNov 12, 2026
8-KCurrent reportNov 10, 2026

Does STIM generate free cash flow?

Neuronetics, Inc. (STIM) generated -$21.18M of free cash flow in fiscal 2025.

How much operating cash flow does STIM produce?

Operating cash flow was -$20.37M, before capital expenditures of $801,000.00.